Integral Molecular: Funding, Investors & Team (Aug 2026)
Integral Molecular's goal is to develop and employ innovative technologies to facilitate the discovery of therapies for difficult protein targets. With their extensive expertise in membrane proteins and antibodies, the company has aided over 400 organizations in various fields such as research, drug development, and vaccine creation.
Integral Molecular has raised $9.9M across 3 funding rounds on record, the most recent an undisclosed round of $8.0M announced in Oct 2024.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Integral Molecular Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Integral Molecular Funding Rounds
Integral Molecular raised $1.0M in an undisclosed round announced in Jun 2023.
4 months later, an undisclosed round of $900k was announced in Oct 2023.
1 years later, an undisclosed round of $8.0M was announced in Oct 2024.
Integral Molecular Founders and Leadership Team
Contact details for the Integral Molecular team: 1 of 1 has an email address on file.
Start 14-day free trial →Integral Molecular Funding Compared to Other Biotechnology Startups
Integral Molecular's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Integral Molecular in Biotechnology and Philadelphia
Companies Similar to Integral Molecular
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Integral Molecular Funding FAQs
What does Integral Molecular do?
Integral Molecular's goal is to develop and employ innovative technologies to facilitate the discovery of therapies for difficult protein targets. With their extensive expertise in membrane proteins and antibodies, the company has aided over 400 organizations in various fields such as research, drug development, and vaccine creation.
How much funding has Integral Molecular raised?
Integral Molecular has raised $9.9M across 3 rounds on record. The most recent is an undisclosed round of $8.0M announced in Oct 2024.
When did Integral Molecular last raise funding?
Integral Molecular's most recent funding round on record is an undisclosed round of $8.0M, announced in Oct 2024.
Who founded Integral Molecular?
FundedIQ lists Joseph Rucker (Founder) at Integral Molecular.
Where is Integral Molecular headquartered?
Integral Molecular is based in Philadelphia, Pennsylvania, United States.
How many employees does Integral Molecular have?
Integral Molecular is in the 51-100 employee band.
How does Integral Molecular's funding compare to other Biotechnology startups?
Integral Molecular's latest round of $8.0M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Integral Molecular Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Integral Molecular is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.